For Investors

Discover Global Ventures with Japan Potential

Living Best identifies promising longevity ventures from around the world and helps them validate their opportunity, build trusted relationships and progress toward implementation in Japan.

For investors, this provides earlier visibility into selected companies building evidence, relationships and traction in one of the world’s most important longevity markets.

Through our collaboration with Advanced Telecommunications Research Institute International (ATR) in Keihanna Science City, selected ventures can build real-world evidence in one of Japan’s leading research and innovation ecosystems, and connect with commercial opportunities across Japan.

Japan Is Where the Future Is Happening Now

Japan is already experiencing demographic changes that many other countries will face in the years ahead. That makes it an important market for identifying, testing and understanding the solutions that may shape the future of ageing globally.

Objects
  • Group 8Health & Healthy Ageing
    Better solutions for prevention, healthcare, healthy ageing and quality of life.
  • Group 9Care & Independence
    New approaches that help people remain active, supported and independent for longer.
  • Group 11Robotics, AI & Smart Living
    Technology that can improve everyday life, mobility, care and community participation.
  • Group 10Longer Lives, New Markets
    Demographic change is reshaping housing, work, financial services, mobility and consumer needs.

JAPAN MARKET ACCESS

A Real-World Pathway into Japan

Living Best helps selected ventures validate their Japan opportunity, build trusted relationships and connect with opportunities across Japan.

Our collaboration with ATR in Keihanna Science City provides a real-world environment for validation and engagement, supported by Living Best’s wider professional and ecosystem network across Japan.

For global investors, this means access to promising ventures that are actively building evidence, relationships and commercial traction in Japan.

In collaboration with

ACR logo

Evidence-based Dealflow Curation

Living Best applies a proprietary research and evaluation methodology informed by more than 30 years of Japan market research experience, helping investors understand which longevity innovations show meaningful early signals of relevance, risk and market fit.

We synthesize insight from users, experts, institutions, and market participants to provide an evidence-based foundation for identifying high-potential opportunities.

For investors, this supports:

• clearer visibility into ventures that may succeed in Japan
early identification of risks and assumptions that require scrutiny
• stronger differentiation between promising and weaker Japan-market fit

fewer blind spots before capital is deployed

Investors are also welcome to introduce longevity ventures interested in Japan for our structured review.

De risked investment approach

Evidence That De-Risks Investment Decisions

Structured evaluation reveals what is supported by real user and ecosystem insight – reducing reliance on founder claims, pitch narratives, or unvalidated projections.

Strategic market entry

Signals on Japan Market Relevance

Our research highlights whether a solution could fit Japan’s advanced aging market – helping investors avoid false positives and spot overlooked, high-potential opportunities.

Regulatory

Multi-Stakeholder Insight

Insights are strengthened through perspectives from users, experts, corporates, and institutions – giving investors a more complete understanding of market readiness and risk.

From Selection to Implementation

Living Best’s venture pathway is designed to help selected companies move beyond market interest and toward real-world implementation in Japan.

1. Assess

Determine whether the venture has a credible commercial opportunity in Japan.

2. Showcase

Test the proposition with relevant stakeholders and build market visibility.

3. Accelerate

Develop trusted relationships with potential partners, customers and collaborators.

4. Implement

Progress toward pilots, funding, distribution and commercial adoption.

5. Scale

Use evidence and partnerships developed in Japan to pursue wider opportunities.

Join a Global Community of Longevity Investors

Get access to curated global longevity dealflow, informed by user, expert and institutional evaluation, with selected ventures building evidence and traction in Japan.

Book a call to tell us about your investment thesis and sectors of interest.